Caspases in ischaemic brain injury and neurodegenerative disease

Apoptosis

Volumn 3, Issue 6, 1998, Pages 387-394

  Deshmukh, M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Apoptosis; Hypoxia ischaemia; Neuronal death; Programmed cell death; Stroke

Indexed keywords

EID: 0011711426     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009602401251     Document Type: Article

References (75)

1. Choi DW. Ischemia-induced neuronal apoptosis. Curr Opin Neurobiol 1996; 6: 667-672.
2. Linnik MD. Role of apoptosis in acute neurodegenerative disorders. Restor Neurol Neurosci 1996; 9: 219-225.
3. Stefanis L, Burke RE, Greene LA. Apoptosis in neurodegenerative disorders. Curr Opin Neurol 1997; 10: 299-305.
4. Mazarakis ND, Edwards AD, Mehmet H. Apoptosis in neural development and disease. Arch Gis Childhood 1997; 77: F165-F170.
5. Savitz SI, Rosenbaum DM. Apoptosis in neurological disease. Neurosurgery 1998; 42: 555-572.
6. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 1993; 75: 641-652.
7. Alnemri ES, Livingston DJ, Nicholson DW, et al. Human ICE/ced-3 protease nomenclature. Cell 1996; 87: 171.
8. Salvesen GS, Dixit VM. Caspases: Intracellular signaling by proteases. Cell 1997; 91: 443-446.
9. Deshmukh M, Vasilakos J, Deckwerth TL, et al. Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE-family proteases. J Cell Biol 1996; 135: 1341-1354.
10. McCarthy MJ, Rubin LL, Philpott KL. Involvement of caspases in sympathetic neuron apoptosis. J Cell Sci 1997; 110: 2165-2173.
11. Stefanis L, Park DS, Yan CYI, et al. Induction of CPP32-like activity in PC12 cells by withdrawal of trophic support-dissociation from apoptosis. J Biol Chem 1996; 271: 30663-30671.
12. Schulz JB, Weller M, Klockgether T. Potassium deprivation-induced apoptosis of cerebellar granule neurons - a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species. J Neurosci 1996; 16: 4696-4706.
13. Armstrong RC, Aja TJ, Hoang KD, et al. Activation of the CED3/ICE-related protease CPP32 in cerebellar granule neurons undergoing apoptosis but not necrosis. J Neurosci 1997; 17: 553-562.
14. Miller TM, Moulder KL, Knudson CM, et al. Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death. J Cell Biol 1997; 139: 205-217.
15. Eldadah BA, Yakovlev AG, Faden AI. The role of CED-3-related cysteine proteases in apoptosis of cerebellar granule cells. J Neurosci 1997; 17: 6105-6113.
16. Keane RW, Srinivasan A, Foster LM, et al. Activation of CPP32 during apoptosis of neurons and astrocytes. J Neurosci Res 1997; 48: 168-180.
17. Gagliardini V, Fernandez PA, Lee RK, et al. Prevention of vertebrate neuronal death by the crmA gene. Science 1994; 263: 826-828.
18. Martinou I, Fernandez PA, Missotten M, et al. Viral proteins E1B19K and p35 protect sympathetic neurons from cell death induced by NGF deprivation. J Cell Biol 1995; 128: 201-208.
19. Milligan CE, Prevette D, Yaginuma H, et al. Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron 1995; 15: 385-393.
20. Troy CM, Stefanis L, Prochiantz A, Greene LA, Shelanski ML. The contrasting roles of ICE family proteases and interleukin-1β in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation. Proc Natl Acad Sci USA 1996; 93: 5635-5640.
21. Taylor J, Gatchalian CL, Keen G, Rubin LL. Apoptosis in cerebellar granule neurones - involvement of interleukin-1-beta converting enzyme-like proteases. J Neurochem 1997; 68: 1598-1605.
22. Tanabe H, Eguchi Y, Shimizu S, Martinou JC, Tsujimoto Y. Death-signalling cascade in mouse cerebellar granule neurons. Eur J Neurosci 1998; 10: 1403-1411.
23. D'mello SR, Aglieco F, Roberts MR, Borodezt K, Haycock JW. A DEVD-inhibited caspase other than cpp32 is involved in the commitment of cerebellar granule neurons to apoptosis induced by k+ deprivation. J Neurochem 1998; 70: 1809-1818.
24. Gottron FJ, Ying HS, Choi DW Caspase inhibition selectively reduces the apoptotic component of oxygen-glucose deprivation-induced cortical neuronal cell death. Mol Cell Neurosci 1997; 9: 159-169.
25. Kuida K, Zheng TS, Na SQ, et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996; 384: 368-372.
26. Choi DW. Excitotoxic cell death. J Neurobiol 1992; 23: 1261-1276.
27. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 1982; 239: 57-69.
28. Pulsinelli WA, Brierley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Annals Neural 1982; 11: 491-498.
29. Du C, Hu R, Csernansky CA, Hsu CY, Choi DW. Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? J Cereb Blood Flow Metab 1996; 16: 195-201.
30. Goto K, Ishige A, Sekiguchi K, et al. Effects of cycloheximide on delayed neuronal death in rat hippocampus. Brain Res 1990; 534: 299-302.
31. Shigeno T, Yamasaki Y, Kato G, et al. Reduction of delayed neuronal death by inhibition of protein synthesis. Neurosci Lett 1990;120:117-119.
32. Loddick SA, MacKenzie A, Rothwell NJ. An ICE inhibitor, z-VAD-DCB attenuates ischaemic brain damage in the rat. Neuroreport 1996; 7: 1465-1468.
33. Hara H, Friedlander RM, Gagliardini V, et al. Inhibition of interleukin-1beta converting enzyme family proteases reduces ischaemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 1997; 94: 2007-2012.
34. Friedlander RM, Gagliardini V, Hara H, et al. Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischaemic brain injury. J Exp Med 1997; 185: 933-940.
35. Schielke GP, Yang GY, Shivers BD, Betz AL. Reduced ischaemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J Cereb Blood Flow Metab 1998; 18: 180-185.
36. Chen J, Nagayama T, Jin KL, et al. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci 1998; 18: 4914-4928.
37. Himi T, Ishizaki Y, Murota S. A caspase inhibitor blocks ischaemia-induced delayed neuronal death in the gerbil. Eur J Neurosci 1998; 10: 777-781.
38. Cheng Y, Deshmukh M, D'Costa A, et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischaemic brain injury. J Clin Invest 1998; 101: 1992-1999.
39. Namura S, Zhu JM, Fink K, et al. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci 1998; 18: 3659-3668.
40. Rothwell NJ, Loddick SA, Stroemer P. Interleukins and cerebral ischaemia. Int Rev Neurobiol 1997; 40: 281-298.
41. Ni B, Wu X, Su Y, et al. Transient global forebrain ischemia induces a prolonged expression of the caspase-3 mRNA in rat hippocampal CA1 pyramidal neurons. J Cereb Blood Flow Metab 1998; 18: 248-256.
42. Kaushal GP, Singh AB, Shah SV. Identification of gene family of caspases in rat kidney and altered expression in ischemia-reperfusion injury. Am J Physiology 1998; 274: F587-F595.
43. Endres M, Namura S, Shimizu SM, et al. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J Cereb BloodFlow Metab 1998; 18: 238-247.
44. Hara H, Fink K, Endres M, et al. Attenuation of transient focal cerebral ischaemic injury in transgenic mice expressing a mutant ICE inhibitory protein. J Cereb BloodFlow Metab 1997; 17: 370-375.
45. Relton JK, Rothwell NJ. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull 1992; 29: 243-246.
46. Yamasaki Y, Matsuura N, Shozuhara H, et al. Interleukin-1 as a pathogenetic mediator of ischaemic brain damage in rats. Stroke 1995; 26: 676-680.
47. Yakovlev AG, Knoblach SM, Fan L, et al. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J Neurosci 1997; 17: 7415-7424.
48. Ma JY, Endres M, Moskowitz MA. Synergistic effects of caspase inhibitors and MK-801 in brain injury after transient focal cerebral ischaemia in mice. Br J Pharmacol 1998; 124: 756-762.
49. Charriaut MC, Ben AY A cautionary note on the use of the TUNEL stain to determine apoptosis. Neuroreport 1995; 7: 61-64.
50. Thomas LB, Gates DJ, Richfield EK, et al. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp Neurol 1995; 133: 265-272.
51. Su JH, Anderson AJ, Cummings BJ, Cotman CW. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 1994; 5: 2529-2533.
52. Lassmann H, Bancher C, Breitschopf H, et al. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathologica 1995; 89: 35-41.
53. Dragunow M, Faull RL, Lawlor P, et al. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport 1995; 6: 1053-1057.
54. Smale G, Nichols NR, Brady DR, Finch CE, Horton WJ. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 1995; 133: 225-230.
55. Li WP, Chan WY, Lai HW, Yew DT. Terminal dUTP nick end labeling (TUNEL) positive cells in the different regions of the brain in normal aging and Alzheimer patients. J Mol Neurosci 1997; 8: 75-82.
56. Migheli A, Cavalla P, Marino S, Schiffer D. A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J Neuropath Exp Neurol 1994; 53: 606-616.
57. Kosel S, Egensperger R, von Eitzen U, Mehraein P, Graeber MB. On the question of apoptosis in the parkinsonian substantia nigra. Acta Neuropathologica 1997; 93: 105-108.
58. Tompkins MM, Basgall EJ, Zamrini E, Hill WD. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Am J Pathology 1997; 150: 119-131.
59. Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci 1995; 15: 3775-3787.
60. Wellington CL, Brinkman RR, O'Kusky JR, Hayden MR. Toward understanding the molecular pathology of Huntington's disease. Brain Pathol 1997; 7: 979-1002.
61. Kim TW, Pettingell WH, Jung YK, Kovacs DM, Tanzi RE. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 1997; 277: 373-376.
62. Goldberg YP, Nicholson DW, Rasper DM, et al. Cleavage of huntingtin by apopain, a proapoptotic cysteme protease, is modulated by the polyglutamine tract. Nat Genetics 1996; 13: 442-449.
63. Miyashita T, Okamuraoho Y, Mito Y, Nagafuchi S, Yamada M. Dentatorubral pallidoluysian atrophy (DRPLA) protein is cleaved by caspase-3 during apoptosis. J Biol Chem 1997; 272: 29238-29242.
64. Wellington CL, Ellerby LM, Hackam AS, et al. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem 1998; 273: 9158-9167.
65. Warrick JM, Paulson HL, Grayboard GL, et al. Expanded polyglutamme protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 1998; 93: 939-949.
66. Loetscher H, Deuschle U, Brockhaus M, et al. Presenilins are processed by caspase-type proteases. J Biol Chem 1997; 272: 20655-20659.
67. Vito P, Ghayur T, D'Adamio L. Generation of anti-apoptotic presenilin-2 polypeptides by alternative transcription, proteolysis, and caspase-3 cleavage. J Biol Chem 1997; 272: 28315-28320.
68. Brockhaus M, Grunberg J, Rohrig S, et al. Caspase-mediated cleavage is not required for the activity of presenilins in amyloidogenesis and notch signaling. Neuroreport 1998; 9: 1481-1486.
69. Yang F, Sun X, Beech W, et al. Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. Am J Pathology 1998; 152: 379-389.
70. Durham HD, Roy J, Dong L, Figlewicz DA. Aggregation of mutant Cu/Zn Superoxide dismutase proteins in a culture model of ALS. J Neuropath Exp Neurol 1997; 56: 523-530.
71. Ghadge GD, Lee JP, Bindokas VP, et al. Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J Neurosci 1997; 17: 8756-8766.
72. Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human Cu,Zn Superoxide dismutase mutation. Science 1994; 264: 1772-1775.
73. Friedlander RM, Brown RH, Gagliardini V, Wang J, Yuan J. Inhibition of ICE slows ALS in mice. Nature 1997; 388: 31.
74. Papermaster DS. Apoptosis of the mammalian retina and lens. Cell Death Differen 1997; 4: 21-28.
75. Davidson FF, Steller H. Blocking apoptosis prevents blindness in Drosophila retinal degeneration mutants. Nature 1998; 391: 587-591.